C. diff. Spores and More

Learn about the importance of laboratory testing in the identification of a C. difficile Infection (CDI). with guests: Jeanine Thomas, President and Founder of the MRSA Survivors Network who is a survivor of both MRSA and C. diff. infections. Dr. Nathan A. Ledeboer, PhD, D(ABMM), Medical Director of Microbiology and Molecular Diagnostics for Wisconsin Diagnostic Laboratories and Froedtert Health.

Dr. Whitney R. Buckel, PharmD, BCPS who is the Infectious Diseases and Antimicrobial Stewardship Clinical Pharmacist at Intermountain Medical Center, and Dr. Steven Cagas, who will give us a brief overview of Roche Diagnostics as well as their new cobas® Cdiff Test.

Join us and our three guests,

Bradley Whitchurch, Founder and Chairman of the Board at Seal Shield, LLC,

Dr. Rosie D. Lyles, MD, Clinical Affairs Head, Research and Department, Clorox Healthcare and

Shelby Lassiter, BSN, RN, CPHQ, CIC, an Infection Preventionist as they come together to discuss

C. diff. infections, hospital-associated infections,

and you will want to know why hand hygiene

alone is not enough, plus infection prevention

measures in the healthcare and home settings.

C.diff Spores and More discuss current C.difficile infection objectives for hospitals within the United Kingdom with James McIlroy, a medical student and founder of a not-for-profit stool bank based within the University of Aberdeen in Scotland.

C. diff. Spores and More discuss Rebiotix

and their clinical study with Rebiotix Founder, CEO

Lee Jones. Listen in as we learn more about

the History, Company profile, Problems they are solving,and product information. Lee will explain What is the microbiome? Their first product RBX 2660 – addressing C. diff, with the Rebiotix platform called MRT (Microbiota Restoration Therapy) and how MRT is different.

This episode we will discuss An Oral Vaccine for C. difficile Infection with Professor Simon Cutting from the Royal Holloway, University of London in the UK, and Chairperson of the C Diff Foundation's Research and Development Committee and Research Community.

Follow us as we discuss the probable causes of C. diff. infection and why it is so prevalent in today's society. Learn what is required to prevent C. diff. infections, and gain a better understanding of the research being focused towards creating prevention against this life-threatening infection; Clostridium difficile.

Join us as guest, and co-founder of Xenex,

Dr. Mark Stibich Epidemiologist and Chief Scientific Officer, discusses UV Disinfection with Xenex

UV Disinfecting Systems + Robots making a clean sweep across the globe zapping ‪#‎Cdiff‬ and all harmful germs that can cause pain, suffering, and double digits in the already stressed healthcare industry. #Cdiff Spores and More ‪#‎CdiffRadio‬ bringing you educational episodes. None of us can do this alone -- All of us can do this together.

Join us as Dr. Hudson Garrett discusses effective ways being used to prevent acquiring a C. difficile infection (CDI) and Carbapenem-resistant Enterobacteriaceae (CRE), treatments available, and environmental safety - infection prevention in hospitals, long-term care, and at home.

Dr. Garrett is a recognized international expert in infection prevention and control. Dr Garrett currently serves as the Chair of the Education Committee for the C Diff Foundation and is a graduate of the Johns Hopkins Fellows Program in Infection Control and Hospital Epidemiology. He was honored as a Who’s Who for Infection Control by Infection Control Today Magazine in 2013 in recognition of his contributions to the field.

This episode of “C. diff. Spores and More” is focused on What is IBS? So you've been diagnosed with IBS (Irritable Bowel Sydrome). Now what? Join us for a discussion about the definition, diagnosis, and treatment of the various forms of IBS with our special guests: Dr. Caterina Oneto,, MD and Dr. Paul Feuerstadt, MD, Both professors and physicians specializing in Gastroenterology with a wealth of knowledge and experience treating patients diagnosed with a CDI and through ongoing scientific/medical research.

In this episode Sepsis will be defined by three Healthcare Clinicians and one Clinician -- a Sepsis survivor. According to the CDC’s National Center for Health Statistics estimates that, based upon information collected for billing purposes, the number of times people were in the hospital with sepsis or septicemia (another word for sepsis) increase.Sepsis is a potentially life-threatening complication of an infection. If sepsis progresses to septic shock, blood pressure drops dramatically, which may lead to death. Anyone can develop sepsis, but it’s most common and most dangerous in older adults or those with weakened immune systems. Early treatment of sepsis improves chances for survival.

Join us with our guest,Cheryl Jones, a grief counselor and a cancer educator and C. diff. survivor, as we discuss anxiety, depression, and grief. Chronic physical illness also defined as a medical condition that lasts for a year or more, have also been experienced by many individuals diagnosed with a C. difficile infection. Patients can become depleted in patience and tolerance from an illness, resulting in a disruption of normal day to day activities due to limited mobility and/or loss of in dependency or from the loss of a loved one. The individual may experience feelings of frustration, anger and even grief. A sense of hopelessness may follow. Like other chronic medical conditions, individuals diagnosed with C. diff.,are also at risk for developing clinical depression and anxiety. Listen in as Cheryl provides information educating those who are struggling through physical limitations and personal losses.